Your browser doesn't support javascript.
loading
Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana.
Bareng, Ontlametse T; Seselamarumo, Sekgabo; Seatla, Kaelo K; Choga, Wonderful T; Bakae, Blessing; Maruapula, Dorcas; Kelentse, Nametso; Moraka, Natasha O; Mokaleng, Baitshepi; Mokgethi, Patrick T; Ditlhako, Tsotlhe R; Pretorius-Holme, Molly; Mbulawa, Mpaphi B; Lebelonyane, Refeletswe; Bile, Ebi Celestin; Gaolathe, Tendani; Shapiro, Roger; Makhema, Joseph M; Lockman, Shahin; Essex, Max; Novitsky, Vlad; Mpoloka, Sununguko W; Moyo, Sikhulile; Gaseitsiwe, Simani.
Afiliação
  • Bareng OT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Medical Sciences, Faculty of Allied Health Professions, University of Botswana, Gaborone, Botswana.
  • Seselamarumo S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Biological Sciences, Faculty of Science, University of Botswana, Gaborone, Botswana.
  • Seatla KK; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Medical Sciences, Faculty of Allied Health Professions, University of Botswana, Gaborone, Botswana.
  • Choga WT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Bakae B; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Maruapula D; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Biological Sciences, Faculty of Science, University of Botswana, Gaborone, Botswana.
  • Kelentse N; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Medical Sciences, Faculty of Allied Health Professions, University of Botswana, Gaborone, Botswana.
  • Moraka NO; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa.
  • Mokaleng B; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Medical Sciences, Faculty of Allied Health Professions, University of Botswana, Gaborone, Botswana.
  • Mokgethi PT; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Biological Sciences, Faculty of Science, University of Botswana, Gaborone, Botswana.
  • Ditlhako TR; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Pretorius-Holme M; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Mbulawa MB; Ministry of Health, Republic of Botswana, Gaborone, Botswana.
  • Lebelonyane R; Ministry of Health, Republic of Botswana, Gaborone, Botswana.
  • Bile EC; FHI 360, Department of Clinical Sciences, Durham, North Carolina, USA.
  • Gaolathe T; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
  • Shapiro R; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Makhema JM; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Lockman S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Essex M; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Novitsky V; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Mpoloka SW; Department of Biological Sciences, Faculty of Science, University of Botswana, Gaborone, Botswana.
  • Moyo S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Gaseitsiwe S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Electronic address: sgaseitsiwe@bhp.org.bw.
J Glob Antimicrob Resist ; 31: 128-134, 2022 12.
Article em En | MEDLINE | ID: mdl-35973671
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Africa Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Botsuana
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: Africa Idioma: En Revista: J Glob Antimicrob Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Botsuana